These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11596529)

  • 1. Botulinum toxin in motor disorders: practical considerations with emphasis on interventional neurophysiology.
    Traba López A; Esteban A
    Neurophysiol Clin; 2001 Aug; 31(4):220-9. PubMed ID: 11596529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Movement disorders and botulinum toxin in neurology].
    Sangla S; Trocello JM; Bourdain F; Vidal JS; Gallouedec G; Vidailhet M
    Ann Readapt Med Phys; 2003 Jul; 46(6):307-11. PubMed ID: 12928135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of movement disorders using botulinum toxin].
    Burgunder JM
    Schweiz Med Wochenschr; 1992 Sep; 122(36):1311-6. PubMed ID: 1411387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current clinical applications of botulinum toxin.
    Truong DD; Stenner A; Reichel G
    Curr Pharm Des; 2009; 15(31):3671-80. PubMed ID: 19925419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin treatment of axial and cervical dystonia.
    Benecke R; Dressler D
    Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin in movement disorders.
    Papapetropoulos S; Singer C
    Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of oromandibular motor disorders and facial spasms with injections of botulinum toxin.
    Clark GT
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):727-48. PubMed ID: 14580034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Botulinum toxin therapy: from dreaded biological toxin to standard pharmaceutical].
    Schnider P; Voller B; Moraru K; Auff E
    Wien Klin Wochenschr; 1999 Oct; 111(20):825-9. PubMed ID: 10586486
    [No Abstract]   [Full Text] [Related]  

  • 9. Botulinum toxin therapy of writer's cramp.
    Das CP; Dressler D; Hallett M
    Eur J Neurol; 2006 Feb; 13 Suppl 1():55-9. PubMed ID: 16417599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoring balance in focal limb dystonia with botulinum toxin.
    Sheean G
    Disabil Rehabil; 2007 Dec; 29(23):1778-88. PubMed ID: 18033603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injectable neuromuscular blockade in the treatment of spasticity and movement disorders.
    Tilton AH
    J Child Neurol; 2003 Sep; 18 Suppl 1():S50-66. PubMed ID: 13677571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin treatment of occupational and focal hand dystonia.
    Karp BI
    Mov Disord; 2004 Mar; 19 Suppl 8():S116-9. PubMed ID: 15027063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.
    Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC
    Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin as a new therapy option for voiding disorders: current state of the art.
    Leippold T; Reitz A; Schurch B
    Eur Urol; 2003 Aug; 44(2):165-74. PubMed ID: 12875934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic uses of botulinum toxin.
    Wheeler AH
    Am Fam Physician; 1997 Feb; 55(2):541-5, 548. PubMed ID: 9054223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin therapy for neurologic disorders.
    Tim R; Massey JM
    Postgrad Med; 1992 May; 91(6):327-32, 334. PubMed ID: 1579537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy with botulinum toxin: harnessing nature's most potent neurotoxin.
    Bell MS; Vermeulen LC; Sperling KB
    Pharmacotherapy; 2000 Sep; 20(9):1079-91. PubMed ID: 10999501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on the neurologic applications of botulinum toxins.
    Evidente VG; Adler CH
    Curr Neurol Neurosci Rep; 2010 Sep; 10(5):338-44. PubMed ID: 20567945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin: clinical use.
    Truong DD; Jost WH
    Parkinsonism Relat Disord; 2006 Sep; 12(6):331-55. PubMed ID: 16870487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consensus statement for the management of focal dystonias.
    Williams A
    Br J Hosp Med; 1993 Dec 15-1994 Jan 18; 50(11):655-9. PubMed ID: 8124547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.